Representative Director/CEO, Mr. Toriya participated in the 143rd Annual Meeting of the Pharmaceutical Society of Japan held at Hokkaido University from March 25 to 28, 2023, and gave a lecture at the following symposium.
Symposium of Fusion Session “Nucleic Acids, DDS, and Vaccines”
[Date & Time] March 28, 2023, 15:50 – 17:02
[Chairman] Fumihiko Takeshita (DAIICHI SANKYO COMPANY, LIMITED), Shinya Ooki (Shionogi & Co., Ltd.)
[Title] Characteristics and Future Approaches of HDO in Reducing Toxicity of Nucleic Acid Drugs
At the event, there was a lively discussion on the features and future approach of our platform technology, the third nucleic acid medicine HDO. If you are interested in our HDO technology, please contact us below.
Rena Therapeutics Inc
Business Development Dep.
Tel: +81 3 4243-6081